INTERACTION OF HIV-1 REVERSE-TRANSCRIPTASE WITH A SYNTHETIC FORM OF ITS REPLICATION PRIMER, TRANSFER RNALYS,3

被引:101
作者
BARAT, C
LEGRICE, SFJ
DARLIX, JL
机构
[1] ECOLE NORMAL SUPER LYON, LABORETRO, 46 ALLEE ITALIE, F-69364 Lyon, FRANCE
[2] CNRS, CRBGC, F-31062 TOULOUSE, FRANCE
[3] F HOFFMANN LA ROCHE & CO LTD, CENT RES UNIT, CH-4002 BASEL, SWITZERLAND
关键词
D O I
10.1093/nar/19.4.751
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using synthetic oligonucleotides, a gene encoding the HIV-1 replication primer, tRNA(Lys,3), was constructed and placed downstream from a bacteriophage T7 promoter. In vitro transcription of this gene yielded a form of tRNA(Lys,3) which lacks the modified bases characteristic of the natural species and the 3' -C-A-dinucleotide. Synthetic tRNA(Lys,3) annealed to a pbs-HIV1 RNA template can prime cDNA synthesis catalysed by recombinant HIV-1 reverse transcriptase. Trans-DDP crosslinking indicates that this synthetic tRNA is still capable of interacting with HIV-1 RT via a 12-nucleotide portion encompassing the anticodon domain. Gel-mobility shift and competition analyses imply that the affinity of synthetic tRNA for RT is reduced. In contrast to earlier observations, synthetic tRNA is readily competed from RT by natural tRNA(Pro). The reduced affinity of synthetic tRNA(Lys,3) for RT is not appreciably affected by mutations in positions within the loop of the anticodon domain. These results would imply that the overall structure of the anticodon domain of tRNA(Lys,3) is an important factor in its recognition by HIV-1 RT. In addition, modified bases within this, although not absolutely required would appear to make a significant contribution to the enhanced stability of the ribonucleoprotein complex.
引用
收藏
页码:751 / 757
页数:7
相关论文
共 22 条
  • [1] GENETIC-VARIABILITY OF THE AIDS VIRUS - NUCLEOTIDE-SEQUENCE ANALYSIS OF 2 ISOLATES FROM AFRICAN PATIENTS
    ALIZON, M
    WAINHOBSON, S
    MONTAGNIER, L
    SONIGO, P
    [J]. CELL, 1986, 46 (01) : 63 - 74
  • [2] HIV-1 REVERSE-TRANSCRIPTASE SPECIFICALLY INTERACTS WITH THE ANTICODON DOMAIN OF ITS COGNATE PRIMER TRANSFER-RNA
    BARAT, C
    LULLIEN, V
    SCHATZ, O
    KEITH, G
    NUGEYRE, MT
    GRUNINGERLEITCH, F
    BARRESINOUSSI, F
    LEGRICE, SFJ
    DARLIX, JL
    [J]. EMBO JOURNAL, 1989, 8 (11) : 3279 - 3285
  • [3] INHIBITION OF THE P66/P51 FORM OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE BY TRANSFER RNALYS
    BORDIER, B
    TARRAGOLITVAK, L
    SALLAFRANQUEANDREOLA, ML
    ROBERT, D
    THARAUD, D
    FOURNIER, M
    BARR, PJ
    LITVAK, S
    SARIHCOTTIN, L
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (03) : 429 - 436
  • [4] DIRHEIMER G, 1983, RECENT RESULTS CANC, V84, P15
  • [5] HARADA F, 1979, J BIOL CHEM, V254, P979
  • [6] HARADA F, 1975, J BIOL CHEM, V250, P3487
  • [7] GENETIC APPROACH TO FACILITATE PURIFICATION OF RECOMBINANT PROTEINS WITH A NOVEL METAL CHELATE ADSORBENT
    HOCHULI, E
    BANNWARTH, W
    DOBELI, H
    GENTZ, R
    STUBER, D
    [J]. BIO-TECHNOLOGY, 1988, 6 (11): : 1321 - 1325
  • [8] KRIEG PA, 1987, METHOD ENZYMOL, V155, P397
  • [9] ENZYMATIC-SYNTHESIS OF BIOTIN-LABELED POLYNUCLEOTIDES - NOVEL NUCLEIC-ACID AFFINITY PROBES
    LANGER, PR
    WALDROP, AA
    WARD, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11): : 6633 - 6637
  • [10] LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x